Organogenesis Holdings Inc. revenue
Organogenesis Holdings Inc.'s revenue was $564m in fiscal 2025, up 17.0% on the year before. Since fiscal 2016 ($139m) it has grown at a compound 16.9% a year. Over the last twelve months it was $457m.
Revenue history
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 139 | 199 | 193 | 261 | 338 | 467 | 451 | 433 | 482 | 564 | 457 |
| Growth on the year before | — | +43.1% | −2.5% | +34.9% | +29.6% | +38.2% | −3.5% | −3.9% | +11.3% | +17.0% | — |
| Gross profit | 91 | 137 | 125 | 185 | 251 | 353 | 346 | 327 | 366 | — | — |
| Gross margin | 65.3% | 69.2% | 64.4% | 70.9% | 74.2% | 75.6% | 76.7% | 75.4% | 76.0% | — | — |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Products | $563M | 99.8% | ▲ 16.8% |
| Grant | $1.1M | 0.2% | — |
From Organogenesis Holdings Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Organogenesis Holdings Inc. | $457m | 6.5% | 0.0% |
| UFP Technologies Inc | $632m | 7.3% | 17.8% |
| Mimedx Group, Inc. | $304m | -22.8% | -0.6% |
| Embecta Corp. | $1.02bn | -7.6% | -2.9% |
| Orasure Technologies Inc | $112m | -18.9% | -38.4% |
| ICU Medical Inc | $2.16bn | -9.0% | -2.0% |
Compare with peers
- UFP Technologies Inc revenue
- Mimedx Group, Inc. revenue
- Embecta Corp. revenue
- Orasure Technologies Inc revenue
- ICU Medical Inc revenue
Head to head: ORGO vs UFPTMDXG vs ORGOEMBC vs ORGOORGO vs OSUR
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies